Literature DB >> 3676519

Serum transferrin receptor as a new index of erythropoiesis.

Y Kohgo1, Y Niitsu, H Kondo, J Kato, N Tsushima, K Sasaki, M Hirayama, T Numata, T Nishisato, I Urushizaki.   

Abstract

Serum transferrin receptors were measured by a sandwich radioimmunoassay procedure in patients with iron deficiency anemia, autoimmune hemolytic anemia and aplastic anemia. The mean circulating transferrin receptor concentration of normal subjects and patients with iron deficiency anemia, autoimmune hemolytic anemia and aplastic anemia are 253 +/- 82 ng/mL, 730 +/- 391 ng/mL, 1,426 +/- 1,079 ng/mL, and 182 +/- 39 ng/mL, respectively. The values for those with iron deficiency anemia and autoimmune hemolytic anemia were significantly higher than that of normal controls and the values for those with aplastic anemia were lower than that of normal controls. After iron supplementation in iron deficiency anemia, the serum transferrin receptor values increased twofold over those of pretreatment values. This increase parallels an increase in peripheral reticulocytes. Therefore, the number of circulating transferrin receptors in anemic patients may reflect the level of bone marrow erythropoiesis and is a potentially useful new index for red cell production.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3676519

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  The importance of serum transferrin receptor level in the diagnosis of functional iron deficiency due to recombinant human erythropoietin treatment in haemodialysis patients.

Authors:  H Z Tonbul; H Kaya; N Y Selçuk; S B Tekin; A San; F Akçay; E Akarsu
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

Review 2.  Transferrin receptor in tissue and serum: updated clinical significance of soluble receptor.

Authors:  Yutaka Kohgo; Yoshihiro Torimoto; Junji Kato
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

3.  Suppression of hepcidin during anemia requires erythropoietic activity.

Authors:  Mihwa Pak; Miguel A Lopez; Victroia Gabayan; Tomas Ganz; Seth Rivera
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

4.  Efficacy and tolerability of a prolonged release ferrous sulphate formulation in iron deficiency anaemia: a non-inferiority controlled trial.

Authors:  Mohammed Zaim; Leonardo Piselli; Pino Fioravanti; Claire Kanony-Truc
Journal:  Eur J Nutr       Date:  2011-06-04       Impact factor: 5.614

5.  Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromes.

Authors:  Pat Mahachoklertwattana; Pensri Pootrakul; Ampaiwan Chuansumrit; Lulin Choubtum; Arporn Sriphrapradang; Rojana Sirisriro; Rajata Rajatanavin
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

6.  New diagnostic tools for delineating iron status.

Authors:  Yelena Z Ginzburg
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 7.  The relevance of the intestinal crypt and enterocyte in regulating iron absorption.

Authors:  Phillip S Oates
Journal:  Pflugers Arch       Date:  2007-05-01       Impact factor: 3.657

8.  Crosstalk between Iron Metabolism and Erythropoiesis.

Authors:  Huihui Li; Yelena Z Ginzburg
Journal:  Adv Hematol       Date:  2010-06-10

9.  Anaemia in Systemic Lupus Erythematosus Based on Iron Studies and Soluble Transferrin Receptor Levels.

Authors:  Salony Mittal; Preeti Agarwal; Anupam Wakhlu; Ashutosh Kumar; Raj Mehrotra; Saumya Mittal
Journal:  J Clin Diagn Res       Date:  2016-06-01

10.  Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis.

Authors:  G Vreugdenhil; B Manger; C Nieuwenhuizen; R A Feelders; H G van Eijk; A J Swaak
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.